Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors

  • A. J. Kaumann


5-Hydroxytryptamine (5 HT)-induced contractions were investigated on cocaine-treated strips of bovine large coronary arteries.
  1. 1.

    The α2-adrenoceptor blockers rauwolscine and yohimbine antagonized competitively 5 HT-induced contractions. The estimated equilibrium dissociation constantsKB (−log mol/l) were 7.1 for rauwolscine and 7.3 for yohimbine. The affinity of yohimbine for the receptors mediating the response to 5HT appears to be 10 times higher than for postsynaptic α1-adrenoceptor but 10 times lower than for postsynaptic vascular α2-adrenoceptor.

  2. 2.

    (−)-Noradrenaline and the α2-adrenoceptor agonist B-HT 920 caused maximum contractions amounting to only 20% and 2%, respectively, of the maximum 5 HT effects. Neither 60 μmol/l B-HT 920 nor 1 μmol/l prazosin antagonized the 5 HT effect.

  3. 3.

    Ketanserin was a competitive antagonist (KB=9.2 (−log mol/l)) of the effects of 5 HT. Combinations of rauwolscine or yohimbine with ketanserin antagonized the 5 HT effects as expected from competition of the 4 drugs for a single class of receptor.

  4. 4.

    The evidence is consistent with an interaction of 5 HT, ketanserin, rauwolscine and yohimbine with 5 HT2 receptors. α-Adrenoceptors only play a minor role in large coronary arteries and appear not to be involved in the 5 HT-induced contractions. A possible clinical involvement of 5 HT in coronary artery spasm is discussed.


Key words

5 HT2 receptors Large coronary arteries Yohimbine Rauwolscine Ketanserin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol 14:48–58Google Scholar
  2. Awouters F, Leysen JE, De Clerck F, van Nueten JM (1982) General pharmacological profile of ketanserin (R 41468), a selective 5-HT2 receptor antagonist. In: De Clerck F, Vanhoutte PM (eds) 5-Hydroxytryptamine in peripheral reactions. Raven Press, New York, pp. 193–197Google Scholar
  3. Blinks JR (1965) Convenient apparatus for recording contractions of isolated muscle. J Appl Physiol 20:755–757Google Scholar
  4. Brazenor RM, Angus JA (1981) Ergometrine contracts isolated canine coronary arteries by a serotonergic mechanism: No role for alpha adrenoceptors. J Pharmacol Exp Ther 218:530–536Google Scholar
  5. Brazenor RM, Angus JA (1982) Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol 81:569–576Google Scholar
  6. Consolazione A, Milstein C, Wright B, Cuello AC (1981) Immunocytochemical detection of serotonin with monoclonal antibodies. J Histochem Cytochem 29:1425–1430Google Scholar
  7. Constantine JW, Lebel W, Archer R (1982) Functional postsynaptic β but not α1-adrenoceptor in dog saphenous vein exposed to phenoxybenzamine. Eur J Pharmacol 85:325–329Google Scholar
  8. De Mey J, Vanhoutte PM (1981) Uneven distribution of postjunctional alpha1- and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48:875–884Google Scholar
  9. Feniuk W, Humphrey PPA, Watts AD (1981) Further characterization of pre- and post-junctional receptor for 5-hydroxytryptamine in isolated vasculature. Br J Pharmacol 73:191P-192PGoogle Scholar
  10. Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br Pharmacol 12:323–328Google Scholar
  11. Holtz J, Saeed M, Sommer O, Bassenge E (1982) Norepinephrine constricts the canine coronary bed via postsynaptic α2-adrenoceptor. Eur J Pharmacol 82:199–202Google Scholar
  12. Innes IR (1962) An action of 5-hydroxytryptamine on adrenaline receptors. Br J Pharmacol 19:427–442Google Scholar
  13. Kaumann AJ (1982) Yohimbine, rauwolscine and ketanserin antagonize 5HT contractures through the same receptors in large coronary arteries of calf. Pflügers Arch 394:R89Google Scholar
  14. Kaumann AJ, Mc Inerny T, Gilmour DP, Blinks JR (1980) Comparative assessment of β-receptor blocking agents as simple competitive antagonists in isolated heart muscle. Similarity of inotropic and chronotropic blocking potencies against isoproterenol. Naunyn-Schmiedeberg's Arch Pharmacol 311:219–236Google Scholar
  15. Kaumann AJ, Breuer H-WM, Arnold G (1982) Heterogeneous spare receptors for serotonin (5HT) in bovine coronary arteries. Pflügers Arch 392:R36Google Scholar
  16. Lambert GA, Lang WJ, Friedman E, Meller E, Gershon S (1978) Pharmacological and biochemical properties of isomeric yohimbine alkaloids. Eur J Pharmacol 49:39–48Google Scholar
  17. Lemoine H, Kaumann AJ (1982) A novel analysis of concentration-dependence of partial agonism. Ring-demethylation of bupranolol results in a high-affinity partial agonist (K 105) for myocardial and tracheal β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 320:130–144Google Scholar
  18. Lemoine H, Kaumann AJ (1983) A model for the interaction of antagonists with two receptor-subtypes characterized by a Schildplot with apparent slope unity. Agonist-dependent enantiomeric affinity ratios for bupranolol in trachae but not in right atria of guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 322:111–120Google Scholar
  19. Leysen JE, Awouters F, Kenis L, Laduron PM, Vandenberg J, Janssen PAJ (1981) Receptor binding profile of R 41468, a novel antagonist at 5HT2 receptors. Life Sci 28:1015–1022Google Scholar
  20. Leysen JE, Niemegeers CJE, van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R 41468), a selective3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21:301–314Google Scholar
  21. Lues I, Schümann HJ (1982) Characterization of postsynaptic α-adrenoceptors in the isolated saphenous vein of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 321:R65Google Scholar
  22. Mena MA, Vidrio H (1976) On the mechanism of the coronary dilator effect of serotonin in the dog. Eur J Pharmacol 36:1–5Google Scholar
  23. Morris TH, Sandrock K, Kaumann AJ (1981)3H-(−)-bupranolol (3H-Bu), a new β-adrenoceptor radioligand: Binding to cat heart β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:19–25Google Scholar
  24. Nickerson M (1971) Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 4th edition. Collier-MacMillan, pp 549–584Google Scholar
  25. Paton WDM, Rand HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc Roy Soc Ser B (London) 163:1–44Google Scholar
  26. Peroutka ST, Snyder SH (1979) Multiple serotonin receptors: Differential binding of (3H)5-hydroxytryptamine, (3H)lysergic acid diethylamine and (3H)spiroperidol. Mol Pharmacol 16:687–699Google Scholar
  27. Porquet M-F, Pourrias B, Santamaria R (1982) Effects of 5-hydroxytryptamine on canine isolated coronary arteries. Br J Pharmacol 75:305–310Google Scholar
  28. Shepperson NB, Langer SZ (1981) The effects of the 2-amino-tetrahydronaphthalene derivative M7, a selective α2-adrenoceptor in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 318:10–13Google Scholar
  29. Snipes RL, Thoenen H, Tanzer JP (1968) Fine structure localization of exogeneous 5-HT in vesicles of adrenergic nerve terminals. Experientia (Basel) 24:1026–1027Google Scholar
  30. Starke K (1981) α-adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–235Google Scholar
  31. Thoa NB, Eccleston D, Axelrod J (1969) The accumulation of14C-serotonin in the guinea-pig vas deferens. J Pharmacol Exp Ther 169:68–73Google Scholar
  32. Timmermans PBMWM, de Jonge A, van Meel JCA, Slothorst-Grisdijk FP, Lam E, van Zwieten PA (1981) Characterization of α-adrenoceptor populations. Quantitative relationships between cardiovascular effects initiated at central and peripheral α-adrenoceptors. J Med Chem 24:502–507Google Scholar
  33. Van Meel JCA, de Jonge A, Kalkman HO, Wilffert B, Timmermans PBMWM, van Zwieten PA (1981) Vascular smooth muscle contraction initiated by postsynaptic α-adrenoceptor activations is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205–212Google Scholar
  34. Van Nueten JM, Janssen PAJ, van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM (1981) Vascular effects of ketanserin (R 41468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther 218:217–230Google Scholar
  35. Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 308:127–136Google Scholar

Copyright information

© Springer-Verlag 1983

Authors and Affiliations

  • A. J. Kaumann
    • 1
  1. 1.Lehrstuhl für Klinische PhysiologiePhysiologisches Institut der Universität DüsseldorfDüsseldorf 1Federal Republic of Germany

Personalised recommendations